134 related articles for article (PubMed ID: 7629117)
1. Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments.
Kolakowski LF; Lu B; Gerard C; Gerard NP
J Biol Chem; 1995 Jul; 270(30):18077-82. PubMed ID: 7629117
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
3. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
4. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and expression of the functional rat C5a receptor.
Rothermel E; Zwirner J; Vogt T; Rabini S; Götze O
Mol Immunol; 1997; 34(12-13):877-86. PubMed ID: 9464523
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding.
Mery L; Boulay F
Eur J Haematol; 1993 Nov; 51(5):282-7. PubMed ID: 8282089
[TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
Cain SA; Coughlan T; Monk PN
Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
[TBL] [Abstract][Full Text] [Related]
8. Site directed mutagenesis of the complement C5a receptor--examination of a model for its interaction with the ligand C5a.
Pease JE; Burton DR; Barker MD
Mol Immunol; 1994 Jul; 31(10):733-7. PubMed ID: 8035835
[TBL] [Abstract][Full Text] [Related]
9. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain.
Naik N; Giannini E; Brouchon L; Boulay F
J Cell Sci; 1997 Oct; 110 ( Pt 19)():2381-90. PubMed ID: 9410877
[TBL] [Abstract][Full Text] [Related]
10. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
11. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
[TBL] [Abstract][Full Text] [Related]
12. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
13. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
14. Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries.
Cain SA; Ratcliffe CF; Williams DM; Harris V; Monk PN
J Immunol Methods; 2000 Nov; 245(1-2):139-45. PubMed ID: 11042291
[TBL] [Abstract][Full Text] [Related]
15. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
Zahn S; Zwirner J; Spengler HP; Götze O
Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
[TBL] [Abstract][Full Text] [Related]
16. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.
Hennecke M; Kola A; Baensch M; Wrede A; Klos A; Bautsch W; Köhl J
Gene; 1997 Jan; 184(2):263-72. PubMed ID: 9031638
[TBL] [Abstract][Full Text] [Related]
17. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
Baranski TJ; Herzmark P; Lichtarge O; Gerber BO; Trueheart J; Meng EC; Iiri T; Sheikh SP; Bourne HR
J Biol Chem; 1999 May; 274(22):15757-65. PubMed ID: 10336477
[TBL] [Abstract][Full Text] [Related]
19. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.
Farzan M; Schnitzler CE; Vasilieva N; Leung D; Kuhn J; Gerard C; Gerard NP; Choe H
J Exp Med; 2001 May; 193(9):1059-66. PubMed ID: 11342590
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
